Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? (2012)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; DALL'OGLIO, MARCOS FRANCISCO - FM
- Unidade: FM
- DOI: 10.1016/j.urolonc.2010.10.010
- Subjects: INCONTINÊNCIA URINÁRIA; DISFUNÇÃO ERÉTIL; BIÓPSIA; ESTADIAMENTO DE NEOPLASIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Urologic Oncology
- ISSN: 1078-1439
- Volume/Número/Paginação/Ano: v. 30, n. 6, p. 794-797, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KATZ, Betina et al. Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?. Urologic Oncology, v. 30, n. 6, p. 794-797, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2010.10.010. Acesso em: 30 dez. 2025. -
APA
Katz, B., Srougi, M., Dall’Oglio, M., Nesrallah, A. J., Sant’Anna, A. C., Pontes Jr., J., et al. (2012). Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? Urologic Oncology, 30( 6), 794-797. doi:10.1016/j.urolonc.2010.10.010 -
NLM
Katz B, Srougi M, Dall’Oglio M, Nesrallah AJ, Sant’Anna AC, Pontes Jr. J, Reis ST, Sañudo A, Camara-Lopes LH, Leite KRM. Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? [Internet]. Urologic Oncology. 2012 ; 30( 6): 794-797.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.urolonc.2010.10.010 -
Vancouver
Katz B, Srougi M, Dall’Oglio M, Nesrallah AJ, Sant’Anna AC, Pontes Jr. J, Reis ST, Sañudo A, Camara-Lopes LH, Leite KRM. Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? [Internet]. Urologic Oncology. 2012 ; 30( 6): 794-797.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.urolonc.2010.10.010 - Hiperplasia benigna da próstata
- Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
- Hiperplasia prostática benigna
- Procedimentos diagnósticos em HPB
- Genetic polymorphism of matrix metalloproteinase 9: implications in PCA diagnosis
- Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
- Stage, Grade and Behavior of Bladder Urothelial Carcinoma Defined by the MicroRNA Expression Profile
- Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
- Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors?
- Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer
Informações sobre o DOI: 10.1016/j.urolonc.2010.10.010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
